Nuclear localization of α-synuclein and its interaction with histones

被引:260
作者
Goers, J
Manning-Bog, AB
McCormack, AL
Millett, IS
Doniach, S
Di Monte, DA
Uversky, VN [1 ]
Fink, AL
机构
[1] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA
[2] Calif Polytech State Univ San Luis Obispo, Parkinsons Inst, Dept Chem & Biochem, Sunnyvale, CA 94089 USA
[3] Stanford Univ, Dept Chem, Stanford, CA 94305 USA
[4] Stanford Univ, Dept Phys, Stanford, CA 94305 USA
关键词
D O I
10.1021/bi0341152
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The aggregation of alpha-synuclein is believed to play an important role in the pathogenesis of Parkinson's disease as well as other neurodegenerative disorders ("synucleinopathies"). However, the function of alpha-synuclein under physiologic and pathological conditions is unknown, and the mechanism of alpha-synuclein aggregation is not well understood. Here we show that alpha-synuclein forms a tight 2:1 complex with histories and that the fibrillation rate of alpha-synuclein is dramatically accelerated in the presence of histories in vitro. We also describe the presence of cc-synuclein and its co-localization with histories in the nuclei of nigral neurons from mice exposed to a toxic insult (i.e., injections of the herbicide paraquat). These observations indicate that translocation into the nucleus and binding with histones represent potential mechanisms underlying alpha-synuclein pathophysiology.
引用
收藏
页码:8465 / 8471
页数:7
相关论文
共 36 条
[21]   The herbicide paraquat causes up-regulation and aggregation of α-synuclein in mice -: Paraquat and α-synuclein [J].
Manning-Bog, AB ;
McCormack, AL ;
Li, J ;
Uversky, VN ;
Fink, AL ;
Di Monte, DA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (03) :1641-1644
[22]  
MAROTEAUX L, 1988, J NEUROSCI, V8, P2804
[23]   Dopaminergic loss and inclusion body formation in α-synuclein mice:: Implications for neurodegenerative disorders [J].
Masliah, E ;
Rockenstein, E ;
Veinbergs, I ;
Mallory, M ;
Hashimoto, M ;
Takeda, A ;
Sagara, Y ;
Sisk, A ;
Mucke, L .
SCIENCE, 2000, 287 (5456) :1265-1269
[24]   Effect of environmental factors on the kinetics of insulin fibril formation: Elucidation of the molecular mechanism [J].
Nielsen, L ;
Khurana, R ;
Coats, A ;
Frokjaer, S ;
Brange, J ;
Vyas, S ;
Uversky, VN ;
Fink, AL .
BIOCHEMISTRY, 2001, 40 (20) :6036-6046
[25]   Mutation in the alpha-synuclein gene identified in families with Parkinson's disease [J].
Polymeropoulos, MH ;
Lavedan, C ;
Leroy, E ;
Ide, SE ;
Dehejia, A ;
Dutra, A ;
Pike, B ;
Root, H ;
Rubenstein, J ;
Boyer, R ;
Stenroos, ES ;
Chandrasekharappa, S ;
Athanassiadou, A ;
Papapetropoulos, T ;
Johnson, WG ;
Lazzarini, AM ;
Duvoisin, RC ;
DiIorio, G ;
Golbe, LI ;
Nussbaum, RL .
SCIENCE, 1997, 276 (5321) :2045-2047
[26]   α-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies [J].
Spillantini, MG ;
Crowther, RA ;
Jakes, R ;
Hasegawa, M ;
Goedert, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (11) :6469-6473
[27]   Parkinson disease in twins - An etiologic study [J].
Tanner, CM ;
Ottman, R ;
Goldman, SM ;
Ellenberg, J ;
Chan, P ;
Mayeux, R ;
Langston, JW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (04) :341-346
[28]   Evidence for a partially folded intermediate in α-synuclein fibril formation [J].
Uversky, VN ;
Li, J ;
Fink, AL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (14) :10737-10744
[29]   Metal-triggered structural transformations, aggregation, and fibrillation of human α-synuclein -: A possible molecular link between Parkinson's disease and heavy metal exposure [J].
Uversky, VN ;
Li, J ;
Fink, AL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (47) :44284-44296
[30]   Synergistic effects of pesticides and metals on the fibrillation of α-synuclein:: Implications for Parkinson's disease [J].
Uversky, VN ;
Li, J ;
Bower, K ;
Fink, AL .
NEUROTOXICOLOGY, 2002, 23 (4-5) :527-536